{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:10:03Z","timestamp":1775005803019,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/08122-9"],"award-info":[{"award-number":["2017\/08122-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/18886-1"],"award-info":[{"award-number":["2019\/18886-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Sickle cell disease (SCD) is a genetic disorder that has been associated with priapism. The role of hydroxyurea, a common SCD therapy, in influencing the nitric oxide (NO)-cGMP pathway and its effect on priapism is unclear. To investigate the effect of hydroxyurea treatment on smooth muscle relaxation of corpus cavernosum induced by stimulation of the NO-cGMP pathway in SCD transgenic mice and endothelial NO synthase gene-deficient (eNOS<jats:sup>-\/-<\/jats:sup>) mice, which are used as model of priapism associated with the low bioavailability of endothelial NO. Four-month-old wild-type (WT, C57BL\/6), SCD transgenic, and eNOS<jats:sup>-\/-<\/jats:sup>male mice were treated with hydroxyurea (100 mg\/Kg\/day) or its vehicle (saline) daily for three weeks via intraperitoneal injections. Concentration-response curves for acetylcholine (ACh), sodium nitroprusside (SNP), and electrical field stimulation (EFS) were generated using strips of mice corpus cavernosum. The SCD mice demonstrated an amplified CC relaxation response triggered by ACh, EFS, and SNP. The corpus cavernosum relaxation responses to SNP and EFS were found to be heightened in the eNOS<jats:sup>-\/-<\/jats:sup>group. However, the hydroxyurea treatment did not alter these escalated relaxation responses to ACh, EFS, and SNP in the corpus cavernosum of the SCD group, nor the relaxation responses to EFS and SNP in the eNOS<jats:sup>-\/-<\/jats:sup>group. In conclusion, hydroxyurea is not effective in treating priapism associated with SCD. It is likely that excess plasma hemoglobin and reactive oxygen species, which are reported in SCD, are reacting with NO before it binds to GCs in the smooth muscle of the corpus cavernosum, thus preventing the restoration of baseline NO\/cGMP levels. Furthermore, the downregulation of eNOS in the penis may impair the pharmacological action of hydroxyurea at the endothelial level in SCD mice. This study emphasize the urgency for exploring alternative therapeutic avenues for priapism in SCD that are not hindered by high plasma hemoglobin and ROS levels.<\/jats:p>","DOI":"10.1371\/journal.pone.0292706","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T17:34:44Z","timestamp":1696872884000},"page":"e0292706","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hydroxyurea does not reverse functional alterations of the nitric oxide-cGMP pathway associated with priapism phenotype in corpus cavernosum from sickle cell mouse"],"prefix":"10.1371","volume":"18","author":[{"given":"Dalila Andrade","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danillo Andrade","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"da Silva Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammyris Helena Rebecchi","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiano Beraldi","family":"Calmasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-414X","authenticated-orcid":true,"given":"Leonardo Oliveira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-5570","authenticated-orcid":true,"given":"F\u00e1bio Henrique","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"pone.0292706.ref001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"MJ Telen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0292706.ref002","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","article-title":"Ischemia-Reperfusion Injury in Sickle Cell Disease: From Basics to Therapeutics","volume":"189","author":"J Ansari","year":"2019","journal-title":"Am J Pathol"},{"key":"pone.0292706.ref003","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/CH-189009","article-title":"Nitric oxide pathology and therapeutics in sickle cell disease","volume":"68","author":"DB Kim-Shapiro","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"pone.0292706.ref004","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"A Salonia","year":"2014","journal-title":"Eur Urol"},{"key":"pone.0292706.ref005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jsm.12816","article-title":"Erectile Dysfunction after Sickle Cell Disease-Associated Recurrent Ischemic Priapism: Profile and Risk Factors","volume":"12","author":"UA Anele","year":"2015","journal-title":"J Sex Med"},{"key":"pone.0292706.ref006","article-title":"TSPO ligand FGIN-1-27 controls priapism in sickle cell mice via endogenous testosterone production","author":"B Musicki","year":"2020","journal-title":"J Cell Physiol"},{"key":"pone.0292706.ref007","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/andr.12442","article-title":"Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis","volume":"6","author":"B Musicki","year":"2018","journal-title":"Andrology"},{"key":"pone.0292706.ref008","doi-asserted-by":"crossref","first-page":"e0166291","DOI":"10.1371\/journal.pone.0166291","article-title":"Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse","volume":"11","author":"FH Silva","year":"2016","journal-title":"PloS One"},{"key":"pone.0292706.ref009","article-title":"Beneficial effect of the nitric oxide donor compound 3-(1,3-dioxoisoindolin-2-yl)benzyl nitrate on dysregulated phosphodiesterase 5, NADPH oxidase and nitrosative stress in the sickle cell mouse penis: implication for priapism treatment","author":"FH Silva","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0292706.ref010","doi-asserted-by":"crossref","first-page":"e68028","DOI":"10.1371\/journal.pone.0068028","article-title":"Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress","volume":"8","author":"TJ Bivalacqua","year":"2013","journal-title":"PloS One"},{"key":"pone.0292706.ref011","doi-asserted-by":"crossref","first-page":"e0269310","DOI":"10.1371\/journal.pone.0269310","article-title":"Resveratrol-nitric oxide donor hybrid effect on priapism in sickle cell and nitric oxide-deficient mouse","volume":"17","author":"AK Pinheiro","year":"2022","journal-title":"PloS One"},{"key":"pone.0292706.ref012","doi-asserted-by":"crossref","first-page":"961534","DOI":"10.3389\/fphys.2022.961534","article-title":"Haptoglobin treatment contributes to regulating nitric oxide signal and reduces oxidative stress in the penis: A preventive treatment for priapism in sickle cell disease","volume":"13","author":"S Pereira P da","year":"2022","journal-title":"Front Physiol"},{"key":"pone.0292706.ref013","first-page":"e22535","article-title":"Intravascular hemolysis leads to exaggerated corpus cavernosum relaxation: Implication for priapism in sickle cell disease","volume":"36","author":"APM Iacopucci","year":"2022","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"pone.0292706.ref014","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1743-6109.2010.02123.x","article-title":"Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis","volume":"8","author":"B Musicki","year":"2011","journal-title":"J Sex Med"},{"key":"pone.0292706.ref015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","article-title":"Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis","volume":"189","author":"G Lagoda","year":"2013","journal-title":"J Urol"},{"key":"pone.0292706.ref016","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1743-6109.2012.02798.x","article-title":"Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis","volume":"9","author":"B Musicki","year":"2012","journal-title":"J Sex Med"},{"key":"pone.0292706.ref017","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"HC Champion","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0292706.ref018","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","article-title":"Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters","volume":"14","author":"C-S Lin","year":"2002","journal-title":"Int J Impot Res"},{"key":"pone.0292706.ref019","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"MH Steinberg","year":"2003","journal-title":"JAMA"},{"key":"pone.0292706.ref020","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM199004123221504","article-title":"Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea","volume":"322","author":"GP Rodgers","year":"1990","journal-title":"N Engl J Med"},{"key":"pone.0292706.ref021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","article-title":"Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase","volume":"111","author":"VP Cokic","year":"2003","journal-title":"J Clin Invest"},{"key":"pone.0292706.ref022","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/mol.52.6.1081","article-title":"In Vivo Production of Nitric Oxide in Rats after Administration of Hydroxyurea","volume":"52","author":"J Jiang","year":"1997","journal-title":"Mol Pharmacol"},{"key":"pone.0292706.ref023","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/mol.55.6.1006","article-title":"Detection of Nitrosyl Hemoglobin in Venous Blood in the Treatment of Sickle Cell Anemia with Hydroxyurea","volume":"55","author":"RE Glover","year":"1999","journal-title":"Mol Pharmacol"},{"key":"pone.0292706.ref024","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.2002.03919.x","article-title":"Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea","volume":"119","author":"M Nahavandi","year":"2002","journal-title":"Br J Haematol"},{"key":"pone.0292706.ref025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up","volume":"85","author":"MH Steinberg","year":"2010","journal-title":"Am J Hematol"},{"key":"pone.0292706.ref026","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2010-11-319137","article-title":"Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice","volume":"118","author":"SE Meiler","year":"2011","journal-title":"Blood"},{"key":"pone.0292706.ref027","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells","volume":"108","author":"L-C Wu","year":"2006","journal-title":"Blood"},{"key":"pone.0292706.ref028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ijir.2012.35","article-title":"Phosphodiesterase-9 (PDE9) inhibition with BAY 73\u20136691 increases corpus cavernosum relaxations mediated by nitric oxide-cyclic GMP pathway in mice","volume":"25","author":"FH da Silva","year":"2013","journal-title":"Int J Impot Res"},{"key":"pone.0292706.ref029","doi-asserted-by":"crossref","first-page":"16624","DOI":"10.1073\/pnas.1213790109","article-title":"Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erection","volume":"109","author":"KJ Hurt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0292706.ref030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ucl.2021.06.009","article-title":"Physiology of Erection and Pathophysiology of Erectile Dysfunction","volume":"48","author":"SM MacDonald","year":"2021","journal-title":"Urol Clin North Am"},{"key":"pone.0292706.ref031","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00424-003-1232-7","article-title":"An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice","volume":"448","author":"MR Nangle","year":"2004","journal-title":"Pfl\u00fcg Arch Eur J Physiol"},{"key":"pone.0292706.ref032","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","article-title":"Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape","volume":"24","author":"B Musicki","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"pone.0292706.ref033","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/jpet.118.249581","article-title":"Impairment of Nitric Oxide Pathway by Intravascular Hemolysis Plays a Major Role in Mice Esophageal Hypercontractility: Reversion by Soluble Guanylyl Cyclase Stimulator","volume":"367","author":"F Henrique Silva","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0292706.ref034","doi-asserted-by":"crossref","first-page":"R630","DOI":"10.1152\/ajpregu.00205.2020","article-title":"Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice","volume":"320","author":"CM Taylor","year":"2021","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"pone.0292706.ref035","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3324\/haematol.2010.023325","article-title":"Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model","volume":"95","author":"JD Lebensburger","year":"2010","journal-title":"Haematologica"},{"key":"pone.0292706.ref036","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","article-title":"Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa","volume":"382","author":"CC John","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0292706.ref037","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/jsm.12682","article-title":"Prolonged therapy with the soluble guanylyl cyclase activator BAY 60\u20132770 restores the erectile function in obese mice","volume":"11","author":"FH Silva","year":"2014","journal-title":"J Sex Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T15:45:32Z","timestamp":1703346332000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292706"}},"subtitle":[],"editor":[{"given":"Wesley Lyeverton","family":"Correia Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0292706","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}